Home / Business and Economy / Scientist's Leap: Investing in Improbable Science
Scientist's Leap: Investing in Improbable Science
27 Oct
Summary
- Noubar Afeyan invests millions annually in unproven scientific concepts.
- He co-founded a company in 2010 focused on cellular transformation.
- Afeyan prefers funding internal innovation over external investments.
Biochemical engineer Noubar Afeyan exhibits a distinct preference for investing in highly improbable scientific ideas. Rather than allocating capital to other companies, Afeyan dedicates substantial annual funding to pioneering concepts developed by his internal scientific teams.
One notable initiative, co-founded by Afeyan in 2010, focuses on harnessing the body's own cells for innovative applications. This approach underscores his commitment to nurturing groundbreaking research from its inception.
Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
